Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are older than 16 years of age
- People who have been diagnosed with Systemic Lupus Erythematosus (SLE) — a type of autoimmune disease — where the diagnosis meets the official guidelines set by two major international rheumatology organisations (ACR and EULAR)
- People who have Lupus Nephritis (a form of kidney inflammation related to lupus), where the diagnosis has been confirmed through a kidney biopsy and laboratory examination of the tissue, classified according to recognised medical systems
Who may not be able to join:
- People who have other autoimmune or rheumatological diseases (conditions where the immune system attacks the body)
- People who have lymphoproliferative disorders (diseases affecting the lymph system, such as certain types of lymphoma)
- People who have been diagnosed with cancer
- People who have liver disease
- People who have end-stage kidney disease (very advanced kidney failure)
- People who have diabetic nephropathy (kidney disease caused by diabetes)
- People who have an active infection at the time of the trial
- People who have recently received a blood transfusion
- People who have low levels of vitamin B12, folate, or iron
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 02 +01099082079
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
association of systemic immune-inflammation index (SII) disease activity in systemic lupus erythematosus; association of systemic immune-inflammation index (SII) and lupus nephritis in patients with systemic lupus erythematosus
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.